1 week Ago By Defense World Staff
Prudential Financial Inc. trimmed its position in Silicon Laboratories Inc. (NASDAQ:SLAB – Free Report) by 71.
5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,073 shares of the semiconductor company’s stock after selling 7,692 shares during the period. Prudential Financial Inc.
’s holdings in Silicon Laboratories were worth $382,000 at the end of the most recent quarter. Other hedge funds and other institutional investors have also bought and sold shares of the company. Jones Financial Companies Lllp raised its holdings in Silicon Laboratories by 44.
5% in the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 69 shares during the period. Venturi Wealth Management LLC raised its stake in Silicon Laboratories by 207.
0% during the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock worth $98,000 after buying an additional 530 shares during the period. Asset Management One Co.
Ltd. bought a new position in Silicon Laboratories during the fourth quarter worth about $117,000. KBC Group NV lifted its holdings in Silicon Laboratories by 42.
1% during the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock worth $159,000 after acquiring an additional 379 shares in the last quarter. Finally, Arkadios Wealth Advisors bought a new stake in shares of Silicon Laboratories in the fourth quarter worth about $237,000.
Insiders Place Their BetsIn related news, Director William G. Bock sold 2,000 shares of the stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $140.
77, for a total value of $281,540.00. Following the completion of the transaction, the director now owns 32,115 shares of the company’s stock, valued at $4,520,828.
55. This represents a 5.86 % decrease in their position.
The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Navdeep S. Sooch sold 2,360 shares of the business’s stock in a transaction on Wednesday, February 5th.
The stock was sold at an average price of $149.00, for a total transaction of $351,640.00.
Following the sale, the director now directly owns 400,567 shares in the company, valued at approximately $59,684,483. The trade was a 0.59 % decrease in their position.
The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,360 shares of company stock valued at $782,610. 1.
60% of the stock is currently owned by corporate insiders. Silicon Laboratories Trading Up 15.4 %Shares of SLAB stock opened at $99.
41 on Thursday. The stock has a 50 day simple moving average of $129.44 and a 200 day simple moving average of $122.
80. Silicon Laboratories Inc. has a 1 year low of $82.
82 and a 1 year high of $160.00. The stock has a market cap of $3.
23 billion, a P/E ratio of -16.74 and a beta of 1.33.
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, hitting analysts’ consensus estimates of ($0.
11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.
69%. The company had revenue of $166.25 million for the quarter, compared to analysts’ expectations of $166.
09 million. During the same quarter last year, the business earned ($1.19) earnings per share.
Silicon Laboratories’s revenue was up 91.4% on a year-over-year basis. Analysts forecast that Silicon Laboratories Inc.
will post -0.97 EPS for the current year. Wall Street Analysts Forecast GrowthSeveral brokerages recently issued reports on SLAB.
KeyCorp boosted their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research report on Wednesday, January 22nd.
Needham & Company LLC reissued a “buy” rating and set a $150.00 price objective on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Benchmark reaffirmed a “buy” rating and issued a $160.
00 price objective on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Susquehanna began coverage on Silicon Laboratories in a report on Tuesday, December 17th. They set a “neutral” rating and a $130.
00 target price for the company. Finally, Stifel Nicolaus lifted their price target on Silicon Laboratories from $135.00 to $145.
00 and gave the company a “buy” rating in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Silicon Laboratories has an average rating of “Hold” and a consensus target price of $136.
20.View Our Latest Stock Report on SLABAbout Silicon Laboratories (Free Report)Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products.
Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.Featured StoriesFive stocks we like better than Silicon LaboratoriesWhat is a penny stock? A comprehensive guideQuantum Computing: The $6.5 Billion Opportunity You Can’t Ignore3 Natural Gas Stocks That Offer Great Dividend YieldsAre Tariffs Threatening Disney’s Comeback Story?Market Cap Calculator: How to Calculate Market CapIs Alphabet a Generational Buying Opportunity at These Levels?.
